secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2021-10-08T23:59:59+00:00
Accession:  0001493152-21-025001
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nephros prelim Q3 2021 net revenue ~$2.6M (+24% YoY); YTD record $7.6M
----------------------------------------------------------------------

- Preliminary net revenue ~$2.6M for Q3 2021, up 24% YoY.
- Year-to-date revenue ~$7.6M, highest in company history (+22% vs 2020).
- Third consecutive quarter of ~25% average YoY growth.
- Pathogen Detection Systems segment contributed nearly $60K in Q3 revenue.
- Cash ~$7.3M at quarter end; full results expected Nov 4, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000149315221025001/0001493152-21-025001-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000149315221025001/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-025001

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer